Sean joined ARCH in 2016, where he has contributed to the formation of numerous companies in life science tools and therapeutics. Sean serves as a board director or observer across these companies and was formerly a board observer at Twist Bioscience (TWST). Prior to ARCH, Sean worked in synthetic biology as part of the early technical team at companies including LS9.

Sean holds a B.S. and M.S. in chemical engineering from Stanford University, where he worked with Jim Swartz on cell-free protein synthesis technologies, and an MBA from the University of Chicago.